ArticleCell2020

Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies.

Kevin R Parker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.